All for Joomla
All for Webmasters
Hemostasis
Acute Care Diagnostics
Autoimmunity
Transfusion
Transplant
#GiveToGain
WTDay
Cyber Health
EEMEA Learning Center - 19
Covid19 Associated Coagulopathies: A Year in Review
Read more...
Discrepancy between SpO2 and SaO2 in a patient with severe anemia
Read more...
Ionized calcium measurements during continuous renal replacement therapy with regional citrate anticoagulation
Read more...
Variability in initial response to standard clopidogrel therapy, delayed conversion to clopidogrel hyper-response, and associated thromboembolic and hemorrhagic complications in patients undergoing endovascular treatment of unruptured cerebral aneury
Read more...
Management of antiplatelet therapy in patients undergoing neuroendovascular procedures
Read more...
Variability of Platelet Reactivity on Antiplatelet Therapy in Neurointervention Procedure
Read more...
Predictive value of platelet reactivity unit (PRU) value for thrombotic and hemorrhagic events during flow diversion procedures: a meta-analysis
Read more...
Laboratory assessments of therapeutic platelet inhibition in endovascular neurosurgery: complication prediction using the VerifyNow P2Y12 assay and thromboelastography with platelet mapping
Read more...
Ticagrelor Is Superior to Clopidogrel in Inhibiting Platelet Reactivity in Patients With Minor Stroke or TIA
Read more...
Risk Factor Analysis of Delayed Intracerebral Hemorrhage After Coil Embolization of Unruptured Cerebral Aneurysms
Read more...
Management of antiplatelet therapy for non-elective invasive procedures or bleeding complications: Proposals from the French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Thrombosis and Haemostasis (GFHT), in collabo
Read more...
2019 EACTS/EACTA/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery
Read more...
Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial
Read more...
Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention
Read more...
Assessment of Bleeding and Thrombosis Based on Aspirin Responsiveness after Continuous-Flow Left Ventricular Assist Device Placement
Read more...
Antiplatelet Therapy Bridging With Cangrelor in Patients With Coronary Stents: A Case Series
Read more...
Weight as an assay-independent predictor of poor response to enteric aspirin in cardiovascular patients
Read more...
Cost-effectiveness of Platelet Function-Guided Strategy with Clopidogrel or Ticagrelor
Read more...
Novel Use of Cangrelor With Heparin During Cardiopulmonary Bypass in Patients With Heparin-Induced Thrombocytopenia Who Require Cardiovascular Surgery: A Case Series
Read more...
Influence of Valve Type and Antiplatelet Regimen on Platelet Reactivity After TAVI: Subanalysis of the REAC-TAVI Trial
Read more...
Platelet Inhibition with Ticagrelor versus Clopidogrel in Diabetic Patients after Percutaneous Coronary Intervention for Chronic Coronary Syndromes
Read more...
The effect of antiplatelet drug on coronary endothelial and microvascular function: comparison with ticagrelor and clopidogrel
Read more...
Novel use of cangrelor in pediatrics: A pilot cohort study demonstrating use in ventricular assist devices
Read more...
Validation of the ABCD-GENE score to identify high platelet reactivity in east Asian patients undergoing percutaneous coronary intervention
Read more...
Effects of switching from clopidogrel to prasugrel at the chronic phase after coronary stenting on antiplatelet action and vascular endothelial function: Switch-Pras study
Read more...
Use of the VerifyNow point of care assay to assess the pharmacodynamic effects of loading and maintenance dose regimens of prasugrel and ticagrelor
Read more...
Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y 12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention
Read more...
Using heparin molecules to manage COVID-2019
Read more...
High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients
Read more...
D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis
Read more...
Venous thromboembolism in critically Ill patients with COVID-19: Results of a screening study for deep vein thrombosis
Read more...
Early coagulation tests predict risk stratification and prognosis of COVID-19
Read more...
COVID-19 Related Coagulopathy: A Distinct Entity?
Read more...
COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure
Read more...
COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET)
Read more...
A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19
Read more...
The compelling arguments for the need of microvascular investigation in COVID-19 critical patients
Read more...
The challenges of diagnosing heparin-induced thrombocytopenia in patients with COVID-19
Read more...
Fibrinolysis and COVID‐19: A plasmin paradox
Read more...
Viral infections and their relationship with catastrophic antiphospholipid syndrome: a possible pathogenic mechanism of severe COVID-19 thrombotic complications
Read more...
Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID-19 patients
Read more...
Role of von Willebrand Factor and ADAMTS-13 in the Pathogenesis of Thrombi in SARS-CoV-2 Infection: Time to Rethink
Read more...
Thromboelastographic Results and Hypercoagulability Syndrome in Patients With Coronavirus Disease 2019 Who Are Critically Ill
Read more...
Coagulopathy in COVID-19: Posted april 24, 2020
Read more...
Heparin - An old drug with multiple potential targets in Covid-19 therapy
Read more...
D-dimer Triage for COVID-19
Read more...
Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis
Read more...
Dynamic relationship between D-dimer and COVID-19 severity
Read more...
Coagulation abnormalities and thrombosis in patients with COVID-19
Read more...
Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis
Read more...
Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis
Read more...
Chronic therapeutic anticoagulation is associated with decreased thrombotic complications in SARS-CoV-2 infection
Read more...
Heparin induced thrombocytopenia antibodies in Covid‐19
Read more...
Potential role of platelets in COVID-19: Implications for thrombosis
Read more...
Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID‐19
Read more...
Curative anticoagulation prevents endothelial lesion in COVID-19 patients
Read more...
Fibrinolysis and COVID-19: A tale of two sites?
Read more...
Practical guidance for the management of adults with immune thrombocytopenia during the COVID-19 pandemic
Read more...
Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus
Read more...
Hemostatic alterations in COVID-19
Read more...
Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility
Read more...
Coagulopathy in COVID-19
Read more...
High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability?
Read more...
Coagulopathy of Coronavirus Disease 2019
Read more...
The unique characteristics of COVID-19 coagulopathy
Read more...
Re The source of elevated plasma D-dimer levels in COVID-19 infection
Read more...
Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence
Read more...
Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS-CoV-2
Read more...
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Read more...
The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome
Read more...
Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID-19
Read more...
Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19
Read more...
Prevalence of Venous Thromboembolism in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis
Read more...
Viscoelastic testing in COVID-19: a possible screening tool for severe disease?
Read more...
Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
Read more...
Heparin-induced thrombocytopenia with thrombosis in COVID-19 adult respiratory distress syndrome
Read more...
Frequency of lupus anticoagulant in COVID-19 patients
Read more...
Thromboprophylaxis in a patient with COVID-19 and severe hemophilia A on emicizumab prophylaxis
Read more...
Lupus anticoagulant is frequent in patients with Covid-19
Read more...
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options
Read more...
Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence
Read more...
Clinical Characteristics of Coronavirus Disease 2019 in China
Read more...
Increased sFLT-1/PlGF ratio in COVID-19: A novel link to angiotensin II-mediated endothelial dysfunction
Read more...
Essential Role of Patient Blood Management in a Pandemic: A Call for Action
Read more...
Current Perspectives of Anticoagulation in Patients With COVID-19
Read more...
COVID-19 Related Arterial Coagulopathy
Read more...
COVID-19 and HELLP: Overlapping Clinical Pictures in Two Gravid Patients
Read more...
Reporting of D-dimer data in COVID-19: some confusion and potential for misinformation
Read more...
COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure
Read more...
Recommendations for Minimal Laboratory Testing Panels in Patients with COVID-19: Potential for Prognostic Monitoring
Read more...
Macrothrombosis and stroke in patients with mild Covid‐19 infection
Read more...
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19
Read more...
Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian Cohort
Read more...
Antiphospholipid antibodies in patients with COVID‐19: A relevant observation?
Read more...
Marked factor V activity elevation in severe COVID‐19 is associated with venous thromboembolism
Read more...
Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom
Read more...
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
Read more...
Coronavirus Disease 2019 (COVID-19) Infection Associated With Antiphospholipid Antibodies and Four-Extremity Deep Vein thrombosis in a Previously Healthy Female
Read more...
The vascular side of COVID-19 disease. Position paper of the International Union of Angiology
Read more...
Start
Prev
1
2
3
4
5
Next
End
Page 2 of 5
Werfen.com.
All rights Reserved.
Privacy Policy
|
Cookies Policy
|
Terms of Service
No Internet Connection